Although not statistically significant, there was a clear trend showing that human CD45+ engraftment was impaired in the rapamycin treatment group in all organs analyzed.
← all excerpts
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.
1
—
—